PlainRecalls
FDA Devices Critical Class I Ongoing

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC

Reported: May 17, 2023 Initiated: March 24, 2023 #Z-1489-2023

Product Description

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC

Reason for Recall

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Details

Recalling Firm
Cordis US Corp
Units Affected
40 units
Distribution
Worldwide distribution.
Location
Miami Lakes, FL

Frequently Asked Questions

What product was recalled?
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC. Recalled by Cordis US Corp. Units affected: 40 units.
Why was this product recalled?
There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 17, 2023. Severity: Critical. Recall number: Z-1489-2023.